BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdel-Ghany S, Raslan S, Tombuloglu H, Shamseddin A, Cevik E, Said OA, Madyan EF, Senel M, Bozkurt A, Rehman S, Sabit H. Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation. 3 Biotech 2020;10:407. [PMID: 32904337 DOI: 10.1007/s13205-020-02391-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Dai X, Wang D, Zhang J. Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis 2021;26:385-414. [PMID: 34236569 DOI: 10.1007/s10495-021-01682-0] [Reference Citation Analysis]
2 Conte M, Fontana E, Nebbioso A, Altucci L. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy. Mar Drugs 2020;19:15. [PMID: 33396307 DOI: 10.3390/md19010015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wawruszak A, Borkiewicz L, Okon E, Kukula-Koch W, Afshan S, Halasa M. Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers (Basel) 2021;13:4700. [PMID: 34572928 DOI: 10.3390/cancers13184700] [Reference Citation Analysis]
4 Rehman S, Almessiere MA, A Al-Suhaimi E, Hussain M, Yousuf Bari M, Mehmood Ali S, Al-Jameel SS, Slimani Y, Khan FA, Baykal A. Ultrasonic Synthesis and Biomedical Application of Mn0.5Zn0.5ErxYxFe2-2xO4 Nanoparticles. Biomolecules 2021;11:703. [PMID: 34066897 DOI: 10.3390/biom11050703] [Reference Citation Analysis]
5 Kawassaki RK, Romano M, Dietrich N, Araki K. Titanium and Iron Oxide Nanoparticles for Cancer Therapy: Surface Chemistry and Biological Implications. Front Nanotechnol 2021;3:735434. [DOI: 10.3389/fnano.2021.735434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hafez DA, Hassanin IA, Teleb M, Khattab SN, Elkhodairy KA, Elzoghby AO. Recent advances in nanomedicine-based delivery of histone deacetylase inhibitors for cancer therapy. Nanomedicine (Lond) 2021;16:2305-25. [PMID: 34551585 DOI: 10.2217/nnm-2021-0196] [Reference Citation Analysis]